Robert Nelsen, Director at AGIOS PHARMACEUTICALS INC (AGIO), sold 80,758 shares at $51.34 ($4.1M) on 2017-03-03, disclosed to the SEC on 2017-03-07.
Open-market sale of $4.1M AGIO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.69 | 31,425 | $1.6M | 38.8% |
| 2 | $50.69 | 31,425 | $1.6M | 38.8% |
| 3 | $51.34 | 8,734 | $448K | 10.9% |
| 4 | $51.34 | 8,734 | $448K | 10.9% |
| 5 | $52.15 | 400 | $21K | 0.5% |
| 6 | $49.43 | 40 |
| $2K |
| 0.0% |
| Total | $50.84 avg | 80,758 | $4.1M | 100% |
| Filing → |
| SANA | BUY | 2024-02-12 | $8.0M | — | Filing → |
| NMRA | BUY | 2023-09-29 | $2.1M | — | Filing → |
| NMRA | BUY | 2023-09-27 | $1.0M | — | Filing → |